Glen Eagle Advisors, LLC Axonics, Inc. Transaction History
Glen Eagle Advisors, LLC
- $593 Billion
- Q3 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 50 shares of AXNX stock, worth $3,549. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$3,549
Previous $3.36 Million
3.51%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AXNX
# of Institutions
234Shares Held
42.1MCall Options Held
83.4KPut Options Held
65.3K-
Vanguard Group Inc Valley Forge, PA5.06MShares$359 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.18MShares$155 Million6.99% of portfolio
-
Fil LTD Hamilton, D02.04MShares$145 Million0.14% of portfolio
-
Westchester Capital Management, LLC Valhalla, NY1.45MShares$103 Million4.89% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...